GANIX Trademark

Trademark Overview


On Thursday, December 5, 2024, a trademark application was filed for GANIX with the United States Patent and Trademark Office. The USPTO has given the GANIX trademark a serial number of 98886839. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, July 30, 2025. This trademark is owned by Makrani Pharma Consulting. The GANIX trademark is filed in the Cosmetics & Cleaning Products category with the following description:

All organic cosmetics, skin care, body care, and hair care products.
ganix

General Information


Serial Number98886839
Word MarkGANIX
Filing DateThursday, December 5, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, July 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkGANICS
Goods and ServicesAll organic cosmetics, skin care, body care, and hair care products.

Classification Information


International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 5, 2024
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMakrani Pharma Consulting
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92067

Trademark Events


Event DateEvent Description
Thursday, December 5, 2024NEW APPLICATION ENTERED
Tuesday, July 29, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 30, 2025ASSIGNED TO EXAMINER
Wednesday, July 30, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 30, 2025NON-FINAL ACTION E-MAILED
Wednesday, July 30, 2025NON-FINAL ACTION WRITTEN